跳至主要内容
临床试验/CTRI/2015/09/006198
CTRI/2015/09/006198已完成未知

Assessment of Efficacy, Safety and Tolerability of therapy with fixed dose combination (FDC) of Cetirizine with Ambroxol and Ambroxol as monotherapy in the treatment of productive Cough: An Open-label, Prospective, Multi-centre, Observational Study

Dr Reddys laboratories Ltd0 个研究点目标入组 250 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Children between over 6 to 18 years of age
  • 2. Male and female children
  • 3. Children having productive cough (cough with expectoration)
  • associated with any of the nasal symptoms (nasal discharge,
  • nasal stuffiness, nasal itching, and Sneezing) since at least
  • previous 8 hours
  • 4. Child willing to provide assent and parents/guardian willing
  • to provide written informed consent
  • 5. Willing and able to understand and comply with all study
  • requirements

排除标准

  • 1.Use of any throat lozenge, throat spray, cough drop, menthol-containing product, or any product with demulcent properties within last 8 hours
  • 2.Use of any cold medication (e.g. nasal or systemic decongestants, antihistamine, expectorant, anti-tussive) within last 8 hours
  • 3.Severe cough requiring hospitalization
  • 4.Presence of fever within last 8 hours
  • 5.Active pulmonary disease such as bronchopneumonia, bronchial asthma or tuberculosis
  • 6.Known allergy to and/or hypersensitivity to ambroxol and/or cetirizine
  • 7.Any other condition, which in the opinion of the clinician/investigator, could interfere significantly with the treatment and assessment process
  • 8.Use of any investigational therapy within 30 days prior to randomization
  • 9.Child not willing to provide assent and parents/guardian not willing to provide written informed consent

研究者

相似试验